42
Participants
Start Date
August 1, 2012
Primary Completion Date
August 1, 2013
Study Completion Date
September 3, 2013
EVARREST™
EVARREST™ Fibrin Sealant Patch is a sterile bio-absorbable combination product consisting of two constituent parts- a flexible matrix and a coating of two biological components (Human Fibrinogen and Human Thrombin).
Topical hemostat
Equine collagen with Human Fibrinogen and Human Thrombin
Standard of Care
SoC is a composite of techniques/methods typically used by the surgeon to control bleeding after conventional methods (i.e. suture, ligation, cautery) are ineffective or impractical.
Clinical Investigation Site #3, New York
Clinical Investigation Site #2, New York
Clinical Investigation Site #5, Indianapolis
Clinical Investigation Site #6, Kansas City
Clinical Investigation Site #4, Camden
Clinical Investigation Site #1, Paterson
Ethicon, Inc.
INDUSTRY